Stockscreener 앱 받기
0.7005
0.03%
0.0002
시간 외 거래:
.71
0.0095
+1.36%
전일 마감가:
$0.7003
열려 있는:
$0.7231
하루 거래량:
138.10K
Relative Volume:
0.59
시가총액:
$31.80M
수익:
$20.35M
순이익/손실:
$-59.43M
주가수익비율:
-0.6801
EPS:
-1.03
순현금흐름:
$-30.96M
1주 성능:
-1.34%
1개월 성능:
-0.07%
6개월 성능:
-22.17%
1년 성능:
-38.01%
1일 변동 폭
$0.7002
$0.7231
1주일 범위
$0.685
$0.7231
52주 변동 폭
$0.5011
$1.55
다리오 헬스 Stock (DRIO) Company Profile
명칭
Dariohealth Corp
전화
972-4-770-6377
주소
322 W 57TH ST. #33B, NEW YORK
DRIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DRIO
Dariohealth Corp
|
0.7005 | 31.80M | 20.35M | -59.43M | -30.96M | -1.03 |
|
VEEV
Veeva Systems Inc
|
280.63 | 46.43B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
58.51 | 12.01B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
61.47 | 10.79B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
103.12 | 9.27B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
38.08 | 7.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
다리오 헬스 Stock (DRIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-29 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2022-05-13 | 업그레이드 | Alliance Global Partners | Neutral → Buy |
| 2021-04-22 | 개시 | Cowen | Outperform |
| 2021-03-23 | 개시 | Stifel | Buy |
| 2021-02-25 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-02-01 | 다운그레이드 | Alliance Global Partners | Buy → Neutral |
| 2020-08-17 | 개시 | Aegis Capital | Buy |
| 2017-08-29 | 개시 | Aegis Capital | Buy |
| 2016-05-09 | 개시 | Rodman & Renshaw | Buy |
모두보기
다리오 헬스 주식(DRIO)의 최신 뉴스
DarioHealth (DRIO) Plans Significant Stock Offering | DRIO Stock News - GuruFocus
DarioHealth (NASDAQ:DRIO) Stock Price Passes Above 50 Day Moving Average – Here’s Why - Defense World
DarioHealth extends preferred stock conversion period By Investing.com - Investing.com Nigeria
DarioHealth extends preferred stock conversion period - Investing.com
DarioHealth Extends Conversion Period for Preferred Stocks - TipRanks
Head to Head Review: Alpha Tau Medical (NASDAQ:DRTS) & DarioHealth (NASDAQ:DRIO) - Defense World
DarioHealth (NASDAQ:DRIO) Now Covered by Litchfield Hills Research - Defense World
DarioHealth (DRIO) Coverage Initiated with 'Buy' Rating by Litch - GuruFocus
DarioHealth (DRIO) Receives Buy Rating with $3 Target from Analy - GuruFocus
DarioHealth (DRIO) Coverage Initiated with 'Buy' Rating by Litchfield Hills | DRIO Stock News - GuruFocus
DarioHealth (NASDAQ:DRIO) Stock Crosses Below 200 Day Moving Average – What’s Next? - Defense World
DarioHealth Corp. (DRIO) Reports Q1 Loss, Misses Revenue Estimates - MSN
DarioHealth Corp. (NASDAQ:DRIO) Q1 2025 Earnings Call Transcript - Insider Monkey
Stifel cuts DarioHealth stock target to $1.50, maintains buy By Investing.com - Investing.com Nigeria
Stifel cuts DarioHealth stock target to $1.50, maintains buy - Investing.com Australia
DarioHealth Reports Increased Revenue Amid Rising Losses - TipRanks
DarioHealth (DRIO) Price Target Reduced Amid Revenue Forecast Adjustments | DRIO Stock News - GuruFocus
DarioHealth earnings beat by $0.24, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: DarioHealth Q1 2025 sees EPS beat, stock dips By Investing.com - Investing.com South Africa
Earnings call transcript: DarioHealth Q1 2025 sees EPS beat, stock dips - Investing.com Nigeria
DarioHealth Corp. (DRIO) reports Q1 loss, misses revenue estimates - FXStreet
DarioHealth (DRIO) Reports Q1 Revenue Below Expectations | DRIO Stock News - GuruFocus
Transcript : DarioHealth Corp., Q1 2025 Earnings Call, May 14, 2025 - marketscreener.com
DarioHealth Earnings: Revenue Up 17%, AI-Driven Cost Cuts Slash Operating Loss by 47% in Digital Health Push - Stock Titan
DarioHealth Corp. SEC 10-Q Report - TradingView
DarioHealth Corp. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
DarioHealth (DRIO) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Dario's Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations - marketscreener.com
DarioHealth Corp. Announces New Research Published in the Journal of Medical Internet Research - marketscreener.com
DarioHealth to Report First Quarter 2025 Results on Wednesday, May 14, 2025 - The Victoria Advocate
DarioHealth Secures New Credit Agreement with Lenders - TipRanks
DarioHealth Closes Strategic Refinancing of Existing Debt Facility of up to $50 Million - citybiz
DarioHealth Closes Strategic Refinancing of Existing Debt Facili - GuruFocus
DarioHealth Closes Strategic Refinancing of Existing Debt Facility of up to $50 Million to Provide Additional Operational Flexibility and Support Growth Initiatives - GuruFocus
DarioHealth Corp. (NASDAQ:DRIO) Holdings Reduced by LPL Financial LLC - Defense World
Indo-Asian News Service - Indo-Asian News Service (IANS)
DarioHealth secures shareholder nod for stock issuances By Investing.com - Investing.com Nigeria
DarioHealth secures shareholder nod for stock issuances - Investing.com
Press Release Distribution & PR Platform - ACCESS Newswire
DarioHealth Corp. to Host Earnings Call - ACCESS Newswire
DarioHealth (NASDAQ:DRIO) Shares Pass Below Two Hundred Day Moving Average – Here’s What Happened - Defense World
DarioHealth says CFO Zvi Ben-David to retire, appoints Chen Franco-Yehuda as successor - MSN
DarioHealth announces executive changes and new CFO appointment - Investing.com Australia
DarioHealth announces executive changes and new CFO appointment By Investing.com - Investing.com India
다리오 헬스 (DRIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
다리오 헬스 주식 (DRIO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Nelson Steven Charles | Chief Commercial Officer |
Sep 10 '24 |
Buy |
0.84 |
5,000 |
4,221 |
45,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Sep 11 '24 |
Buy |
0.80 |
5,000 |
4,022 |
50,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Sep 06 '24 |
Buy |
0.84 |
5,000 |
4,200 |
35,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Sep 05 '24 |
Buy |
0.82 |
5,000 |
4,091 |
30,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Sep 09 '24 |
Buy |
0.80 |
5,000 |
4,000 |
40,000 |
| Raphael Erez | Chief Executive Officer |
Aug 27 '24 |
Buy |
0.88 |
5,000 |
4,400 |
1,937,059 |
| Nelson Steven Charles | Chief Commercial Officer |
Aug 23 '24 |
Buy |
0.95 |
5,000 |
4,750 |
25,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Aug 22 '24 |
Buy |
0.94 |
5,000 |
4,725 |
20,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Aug 21 '24 |
Buy |
0.93 |
5,000 |
4,672 |
15,000 |
| Raphael Erez | Chief Executive Officer |
Aug 21 '24 |
Buy |
0.95 |
5,000 |
4,750 |
1,932,059 |
3.83%
2.55%
자본화:
|
볼륨(24시간):